Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Journal of Cardiovascular Electrophysiology|September 9, 2008
Long- and short-term temporal stability of complex fractionated atrial electrograms in human left atrium during atrial fibrillationDaniel Scherr, Darshan Dalal, Aamir Cheema, et al.Journal of Cardiovascular Translational Research|September 22, 2010
Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathyBoon Yew Tan, Rahul Jain, A Dénise den Haan, et al.Journal of Cardiovascular Electrophysiology|September 23, 2006
Long-term safety and efficacy of circumferential ablation with pulmonary vein isolationAamir Cheema, Jun Dong, Darshan Dalal, et al.Journal of Cardiovascular Electrophysiology|September 14, 2007
Impact of heart rhythm status on registration accuracy of the left atrium for catheter ablation of atrial fibrillationJun Dong, Darshan Dalal, Daniel Scherr, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 5, 2006
Long-term single procedure efficacy of catheter ablation of atrial fibrillationAamir Cheema, Chandrasekhar R Vasamreddy, Darshan Dalal, et al.Journal of the American College of Cardiology|September 24, 2011
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary preventionAditya Bhonsale, Cynthia A James, Crystal Tichnell, et al.Journal of Cardiovascular Electrophysiology|March 10, 2011
Demographic profile of patients undergoing catheter ablation of atrial fibrillationHana Hoyt, Saman Nazarian, Fawaz Alhumaid, et al.The American Journal of Cardiology|July 31, 2007
Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathyKalpana R Prakasa, Jianwen Wang, Harikrishna Tandri, et al.The Oncologist|September 28, 2012
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort studyJohanna C Bendell, Tanios S Bekaii-Saab, Allen L Cohn, et al.American Journal of Human Genetics|June 15, 2006
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathyMark M Awad, Darshan Dalal, Eunpi Cho, et al.Pageof 8